Literature DB >> 9132494

Characterisation of CAH alleles with non-radioactive DNA single strand conformation polymorphism analysis of the CYP21 gene.

A Bobba1, A Iolascon, S Giannattasio, M Albrizio, A Sinisi, F Prisco, F Schettini, E Marra.   

Abstract

The major cause of congenital adrenal hyperplasia (CAH), a common recessive genetic disease, is the deficiency of steroid 21-hydroxylase (21OH), a microsomal enzyme encoded by the CYP21 gene. Although several CAH causing mutations have been identified in the CYP21 gene of patients with 21OH deficiency, genotyping of the 21OH locus is quite complex because of the high frequency of gene conversion and the presence of multiple mutations on single CAH alleles. In order to perform the complete characterisation of the CYP21 gene coding region more simply, we developed a highly sensitive, non-radioactive method allowing DNA single strand conformation polymorphism (DNA-SSCP) analysis. This method was applied to the characterisation of all the exons and intron-exon junctions of the CYP21 gene in five patients affected by the simple virilising form and one affected by the salt wasting form. In all samples showing SSCP signals, direct sequence analysis showed the presence of more than one single sequence variant. In particular, four mutations which are already known to cause the disease, 16 polymorphisms, and one newly identified C to T transition at position 849 were detected. A random sequence analysis, performed on 31 out of 81 exons showing a normal SSCP pattern, shows the method to be highly sensitive: no sequence variant was detected, thus confirming the validity of this non-radioactive DNA-SSCP analysis in characterising the CYP21 gene in patients with steroid 21OH deficiency. Notwithstanding the complete characterisation of all exons and exon/intron junctions of the CYP21 gene, no complete genotype/phenotype correlation was found in the panel of patients analysed, thus suggesting that characterisation of CAH alleles must be extended to outside the coding region of the CYP21 gene, most probably into the promoter region.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9132494      PMCID: PMC1050897          DOI: 10.1136/jmg.34.3.223

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  30 in total

1.  Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency.

Authors:  D Owerbach; L Sherman; A L Ballard; R Azziz
Journal:  Mol Endocrinol       Date:  1992-08

2.  Molecular characterization of 21-hydroxylase deficiency in 70 Italian families.

Authors:  P Carrera; M Ferrari; F Beccaro; I Spiga; M Zanussi; F Rigon; F Braggion; F Zacchello; N Greggio
Journal:  Hum Hered       Date:  1993 May-Jun       Impact factor: 0.444

3.  CYP21/C4 gene organisation in Italian 21-hydroxylase deficiency families.

Authors:  P J Sinnott; C Livieri; M Sampietro; M Marconi; R Harris; F Severi; T Strachan
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

4.  Rapid detection of medium chain acyl-CoA dehydrogenase gene mutations by non-radioactive, single strand conformation polymorphism minigels.

Authors:  A Iolascon; T Parrella; S Perrotta; O Guardamagna; P M Coates; M Sartore; S Surrey; P Fortina
Journal:  J Med Genet       Date:  1994-07       Impact factor: 6.318

5.  Associations between mutations and a VNTR in the human phenylalanine hydroxylase gene.

Authors:  A A Goltsov; R C Eisensmith; D S Konecki; U Lichter-Konecki; S L Woo
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

6.  Haplotypes of the steroid 21-hydroxylase gene region encoding mild steroid 21-hydroxylase deficiency.

Authors:  B Haglund-Stengler; E Martin Ritzén; J Gustafsson; H Luthman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

7.  Molecular analysis of patient and carrier genes with congenital steroid 21-hydroxylase deficiency by using polymerase chain reaction and single strand conformation polymorphism.

Authors:  T Tajima; K Fujieda; K Nakayama; Y Fujii-Kuriyama
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

8.  R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions.

Authors:  A Helmberg; M T Tusie-Luna; M Tabarelli; R Kofler; P C White
Journal:  Mol Endocrinol       Date:  1992-08

9.  Steroid 21-hydroxylase (P450c21): a new allele and spread of mutations through the pseudogene.

Authors:  A Wedell; H Luthman
Journal:  Hum Genet       Date:  1993-04       Impact factor: 4.132

10.  Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations.

Authors:  A Wedell; E M Ritzén; B Haglund-Stengler; H Luthman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

View more
  3 in total

Review 1.  An overview of molecular diagnosis of steroid 21-hydroxylase deficiency.

Authors:  C E Keegan; A A Killeen
Journal:  J Mol Diagn       Date:  2001-05       Impact factor: 5.568

Review 2.  Non-classic adrenal hyperplasia in hyperandrogenism: a reappraisal.

Authors:  C Morán; E S Knochenhauer; R Azziz
Journal:  J Endocrinol Invest       Date:  1998-11       Impact factor: 4.256

Review 3.  Pitfalls in molecular diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia.

Authors:  Mahsa Kolahdouz; Zahra Mohammadi; Parisa Kolahdouz; Masoud Tajamolian; Hossein Khanahmad
Journal:  Adv Biomed Res       Date:  2015-08-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.